Reactions of 2-aminobenzothiazole, 2-aminobenzoxazole, and 2-amino-1-methylbenzimidazole with dimethyl aminofumarate (DMAF) or diethyl ethoxymethylenemalonate (DEEM) led to 2- or 3-carboxy-4H-pyrimido[2,1-b]-benzazol-4-ones, respectively. Subsequent derivatization of these carboxylic acids gave the corresponding tetrazolylcarboxamides and tetrazoles. These acidic compounds were tested in the rat passive cutaneous anaphylaxis (PCA) assay as potential antiallergic agents. Many of the compounds displayed activity comparable to that shown by disodium cromoglycate (DSCG) when tested by the intraperitoneal route, and some, unlike DSCG, also showed activity when tested orally.
The demonstration of bronchodilator effects of ß2-adrenergic agonists delivered by metered dose inhalation (MDI) devices can be useful in the development of new therapies for asthma or assessing the effects of a formulation. MDI formulations of hydroiluoroalkanc (HFA)-134a (a chlorofluorocarbon [CFC]-free propellant), salbutamol in the HFA-134a propellant, CFC-P11/P12 propellant, and salbutamol and formoterol in the CFC propellant were evaluated for their ability to reduce leukotriene D4 (LTD4)-induced bronchoconstriction in guinea pigs using the Konzett-Rossler method. LTD4 challenges were made at various times up to 6 hours after MDI treatment. Neither the placebo vehicle propellants nor the drug formulations affected basal airflow. Only the salbutamol/CFC, formoterol/CFC, and salbutamol/HFA MDI formulations inhibited LTD4-induced bronchoconstriction. One actuation of the MDI device containing salbutamol or formoterol in the CFC propellant produced -100% inhibition of LTD4-induced effects following a 5-minute pretreatment period at doses greater than or equal to 10 pg per actuation. A single actuation of salbutamol (100 fig per actuation) was required to show significant inhibition 30 minutes after aerosol drug delivery (-50% inhibition) and was inactive 1 hour after drug delivery. Inhibition with formoterol was observed at 30 minutes after aerosol delivery at 25 fig per actuation and for up to 6 hours at 100 fig per actuation. Results 41 HAMMERBECK ET AL.of this study indicate that the bronchodilator activity of MDI-delivered /^-adrenergic agonists could be demonstrated using either CFC or HFA propellants in a standard preclinical animal model.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.